{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:34:39Z","timestamp":1760646879353},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018,12,15]]},"DOI":"10.2169\/internalmedicine.1008-18","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T18:46:53Z","timestamp":1533840413000},"page":"3581-3587","source":"Crossref","is-referenced-by-count":1,"title":["Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review"],"prefix":"10.2169","volume":"57","author":[{"given":"Michi","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumasa","family":"Ohara","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Radiology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouki","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kodama","sequence":"additional","affiliation":[{"name":"Kodama Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Sone","sequence":"additional","affiliation":[{"name":"Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl 1): S81-S90, 2014.","DOI":"10.2337\/dc14-S081"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Buzzetti R, Zampetti S, Maddaloni E. Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol 13: 674-686, 2017.","DOI":"10.1038\/nrendo.2017.99"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kumar A, de Leiva A. Latent autoimmune diabetes in adults (LADA) in Asian and European populations. Diabetes Metab Res Rev 33: e2890, 2017.","DOI":"10.1002\/dmrr.2890"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Park Y, Wintergerst KA, Zhou Z. Clinical heterogeneity of type 1 diabetes (T1D) found in Asia. Diabetes Metab Res Rev 33: e2907, 2017.","DOI":"10.1002\/dmrr.2907"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ikegami H, Fujisawa T, Kawabata Y, Noso S, Ogihara T. Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations. Ann N Y Acad Sci 1079: 51-59, 2006.","DOI":"10.1196\/annals.1375.008"},{"key":"6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00125-006-0213-8","volume":"49","author":"E Kawasaki","year":"2006","unstructured":"6. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 49: 828-836, 2006.","journal-title":"Diabetologia","ISSN":"http:\/\/id.crossref.org\/issn\/0012-186X","issn-type":"print"},{"key":"7","unstructured":"7. Committee on Type 1 Diabetes, Japan Diabetes Society. Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM) (2012): report by the Committee on Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus of the Japan Diabetes Society. Diabetol Int 6: 1-7, 2015."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Beyan H, Ola T, David R, Leslie G. Progression of autoimmune diabetes: slowly progressive insulin-dependent diabetes mellitus or latent autoimmune diabetes of adult. Ann N Y Acad Sci 1079: 81-89, 2006.","DOI":"10.1196\/annals.1375.011"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zampetti S, Campagna G, Tiberti C, et al; NIRAD Study Group. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). Eur J Endocrinol 171: 697-704, 2014.","DOI":"10.1530\/EJE-14-0342"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 57: 168-175, 2011.","DOI":"10.1373\/clinchem.2010.148205"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. van Deutekom AW, Heine RJ, Simsek S. The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 25: 117-125, 2008.","DOI":"10.1111\/j.1464-5491.2007.02316.x"},{"key":"12","unstructured":"12. Tanaka S, Awata T, Shimada A, et al.; Committee on Type 1 Diabetes. Clinical characteristics of slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM): 1st subcommittee report on SPIDDM. J Japan Diab Soc 54: 65-75, 2011 (in Japanese, Abstract in English)."},{"key":"13","unstructured":"13. Amrouche Ch, Jamoussi Kamoun H, Trabelsi N, Blouza Chabchoub S. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers. Tunis Med 86: 316-318, 2008."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Trabucchi A, Faccinetti NI, Guerra LL, et al. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype. Autoimmunity 45: 137-142, 2012.","DOI":"10.3109\/08916934.2011.604658"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Huang G, Wang X, Li Z, Li H, Li X, Zhou Z. Insulin autoantibody could help to screen latent autoimmune diabetes in adults in phenotypic type 2 diabetes mellitus in Chinese. Acta Diabetol 49: 327-331, 2012.","DOI":"10.1007\/s00592-010-0196-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Buzzetti R, Spoletini M, Zampetti S, et al; NIRAD Study Group (NIRAD 8). Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes. Diabetes Care 38: 513-520, 2015.","DOI":"10.2337\/dc14-1638"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Xiang Y, Huang G, Shan Z, et al. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5. Acta Diabetol 52: 1121-1127, 2015.","DOI":"10.1007\/s00592-015-0799-8"},{"key":"18","unstructured":"18. Miura J, Tei R, Sorimachi E, et al. A case of slowly progressive type 1 diabetes mellitus with past history of obese and presence of IA-2 antibody but not GAD antibody. J Japan Diab Soc 51: 507-511, 2008 (in Japanese, Abstract in English)."},{"key":"19","unstructured":"19. Yamazaki H, Nagasaki Y, Fujii N, Nagashima S, Osuga J, Ishibashi S. A possible case of slowly progressive type 1 diabetes mellitus in a 90-year-old Japanese man with autoantibody to IA-2 (insulinoma-associated antigen-2). J Japan Diab Soc 59: 661-666, 2016 (in Japanese, Abstract in English)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Soko\u0142owska M, Chobot A, Jarosz-Chobot P. The honeymoon phase - what we know today about the factors that can modulate the remission period in type 1 diabetes. Pediatr Endocrinol Diabetes Metab 22: 66-70, 2016.","DOI":"10.18544\/PEDM-22.02.0053"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Aly H, Gottlieb P. The honeymoon phase: intersection of metabolism and immunology. Curr Opin Endocrinol Diabetes Obes 16: 286-292, 2009.","DOI":"10.1097\/MED.0b013e32832e0693"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 3: 39-40, 2012.","DOI":"10.1111\/j.2040-1124.2012.00207.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kawasaki E. Type 1 diabetes and autoimmunity. Clin Pediatr Endocrinol 23: 99-105, 2014.","DOI":"10.1297\/cpe.23.99"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Juneja R, Hirsch IB, Naik RG, Brooks-Worrell BM, Greenbaum CJ, Palmer JP. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1 (1\/2) diabetes in patients presenting with type 2 diabetes. Metabolism 50: 1008-1013, 2001.","DOI":"10.1053\/meta.2001.25654"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hirata Y, Uchigata Y. Insulin autoimmune syndrome in Japan. Diabetes Res Clin Pract 24 (Suppl): S153-S157, 1994.","DOI":"10.1016\/0168-8227(94)90243-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hoshina S, Miura J, Sugizawa E, Shimura K, Uchigata Y. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree of obesity at diagnosis of diabetes. Diabetol Int 6: 91-97, 2015.","DOI":"10.1007\/s13340-014-0179-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Liu L, Li X, Xiang Y, et al; LADA China Study Group. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3). Diabetes Care 38: 16-21, 2015.","DOI":"10.2337\/dc14-1770"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Morran MP, Vonberg A, Khadra A, Pietropaolo M. Immunogenetics of type 1 diabetes mellitus. Mol Aspects Med 42: 42-60, 2015.","DOI":"10.1016\/j.mam.2014.12.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ikegami H, Noso S, Babaya N, Hiromine Y, Kawabata Y. Genetic basis of type 1 diabetes: similarities and differences between East and West. Rev Diabet Stud 5: 64-72, 2008.","DOI":"10.1900\/RDS.2008.5.64"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Desai M, Zeggini E, Horton VA, et al. An association analysis of the HLA gene region in latent autoimmune diabetes in adults. Diabetologia 50: 68-73, 2007.","DOI":"10.1007\/s00125-006-0513-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Luo S, Lin J, Xie Z, et al. HLA genetic discrepancy between latent autoimmune diabetes in adults and type 1 diabetes: LADA China Study No. 6. J Clin Endocrinol Metab 101: 1693-1700, 2016.","DOI":"10.1210\/jc.2015-3771"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kisand K, Uibo R. LADA and T1D in Estonian population - two different genetic risk profiles. Gene 497: 285-291, 2012.","DOI":"10.1016\/j.gene.2012.01.089"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Committee on Type 1 Diabetes, Japan Diabetes Society. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 52: 2513-2521, 2009.","DOI":"10.1007\/s00125-009-1539-9"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Katahira M, Segawa S, Maeda H, Yasuda Y. Effect of human leukocyte antigen class II genes on acute-onset and slow-onset type 1 diabetes in the Japanese population. Hum Immunol 71: 789-794, 2010.","DOI":"10.1016\/j.humimm.2010.05.020"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Katahira M, Hanakita M, Yasuda Y, Maeda H, Ito T, Segawa S. Effect of human leukocyte antigen class II genes on insulin deficiency in slow-onset type 1 diabetes in the Japanese population. Diabetes Res Clin Pract 93: e33-e36, 2011.","DOI":"10.1016\/j.diabres.2011.03.025"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/24\/57_1008-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T23:42:42Z","timestamp":1544830962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/24\/57_1008-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":35,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1008-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]}}}